Zimmer Biomet
S&P 500
$93.49
+1.14%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Moderate debt: debt-to-equity of 0.6.
- Net profit margin is 8.6%.
- Current assets comfortably cover current liabilities (current ratio 1.98).
- Has paid a dividend in each of the last 5 years on record.
!Watch-points
- Return on equity is on the lower side at 5.6%.
- Return on capital employed is on the lower side at 5.4%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2.42
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Piotroski F-ScoreModerate
4 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$17.83B
Current Price$ 93.49
High / Low$ 106.88 / 79.12
Stock P/E22.691748
Book Value$ 65.48
Dividend Yield1.04%
ROCE5.43%
ROE5.59%
Debt to Equity0.60
Current Ratio1.98
P/B Ratio1.4115533
EPS$ 3.55
Debt$7.52B
PAT Margin8.57%
Cash PAT$1.80B